SCHEMBL27645779

SCHEMBL27645779

CC(=O)OCCn1c(C)cc2cc(F)ccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 6/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TP53 P04637 3/20 0.42
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
GAA P10253 1/20 0.42
PRMT5 O14744 1/20 0.40
MAPT P10636 2/20 0.40
HTT P42858 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
USP2 O75604 1/20 0.40
IDO1 P14902 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
TSHR P16473 2/20 0.39
CCR2 P41597 1/20 0.38
NPC1 O15118 1/20 0.37
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27544474 0.86 TSHR (0.43) ALDH1A1KDM4EHPGDHSD17B10TP53
SCHEMBL27853667 0.82 TP53 (0.62) ALDH1A1KDM4EHSD17B10TP53MEN1
SCHEMBL12371073 0.79 KDM4E (0.45) ALDH1A1KDM4EHPGDHSD17B10TP53
SCHEMBL1598783 0.77 ALDH1A1 (0.56) ALDH1A1KDM4EHPGDHSD17B10MEN1
SCHEMBL13640280 0.76 ALDH1A1 (0.54) ALDH1A1KDM4EHPGDHSD17B10TP53
SCHEMBL2591249 0.76 KDM4E (0.49) ALDH1A1KDM4EHPGDHSD17B10PRMT5
SCHEMBL18509284 0.75 KDM4E (0.45) ALDH1A1KDM4EHPGDHSD17B10TP53
SCHEMBL1422093 0.75 ALDH1A1 (0.55) ALDH1A1KDM4EHPGDHSD17B10TP53
SCHEMBL20853226 0.74 ALDH1A1 (0.68) ALDH1A1KDM4EHPGDHSD17B10TP53
SCHEMBL19506933 0.73 PRMT5 (0.45) ALDH1A1KDM4EHPGDHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101141956-B Use of CRTH2 antagonist compounds in therapy,its preparation method and pharmaceutical uses OXAGEN LTD 2011-04-20 CN disclosed
CN-101932571-A Compounds having crth2 antagonist activity OXAGEN LTD 2010-12-29 CN disclosed
CN-101166721-A With PGD21-acetic acid-indole derivatives with antagonist activity OXAGEN LTD (GB) 2008-04-23 CN disclosed
CN-101141956-A Use of CRTH2 antagonist compounds in therapy OXAGEN LTD (GB) 2008-03-12 CN disclosed
CN-1867547-A Compounds having crth2 antagonist activity OXAGEN LTD (GB) 2006-11-22 CN disclosed